The Fundrise Innovation Fund (VCX), a closed-end fund (CEF) listed on the NYSE, has skyrocketed to trade at a staggering 1,300% premium over its $18.96 net asset value (NAV). Hype around private holdings like OpenAI, Anthropic, and SpaceX drives this surge as their valuations zoom amid record fundraises. Listed recently, VCX offers retail investors rare access to pre-IPO giants, but extreme volatility and lockup dynamics raise red flags.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The timing of VCX’s listing is even more interesting, as three of its private holdings are eyeing a 2026 IPO (initial public offering). Among them, Elon Musk’s space exploration startup, SpaceX, is set to go public in June at a potential $1.5 trillion valuation. Here are the key pros and cons of investing in VCX.
What Is the VCX Fund?
VCX manages $679 million in assets, with top holdings including Anthropic (21%), Databricks (18%), OpenAI (10%), Anduril (7%), and SpaceX (5%). A six-month lockup on shares held by about 100,000 pre-listing investors limits supply, pushing shares from a $31.25 debut to a peak of $380, and even $575 intraday, despite NAV remaining stable.
What Are the Benefits?
Investing in VCX offers access to elite private tech firms, giving retail investors exposure without VC minimums or accreditation hurdles.
Fundrise has a smaller 1.85% annual fee, beating traditional VC’s 2% + 20% carry.
VCX’s holdings have returned roughly 85% since its 2022 inception up to the date of listing. A successful SpaceX IPO could boost NAV, rewarding early buyers before direct shares dilute appeal.
These Are the Major Risks
The 1,300% premium means investors end up paying more than $265 per share for $19 worth of assets, risking over 90% losses if the fund reverts to NAV price post-lockup period in September 2026.
Since VCX is a closed-end fund, the absence of creation/redemption keeps prices untethered, amplifying volatility. VCX faces routine trading halts, with a single-day crash of more than 30% recorded on March 26.
Furthermore, upcoming IPOs of holdings like SpaceX, OpenAI, or Anthropic could erode the fund’s scarcity value, as investors would prefer buying into these companies directly at fair prices.
What SpaceX’s IPO Means for VCX
SpaceX targets a massive NYSE debut in June 2026 via banks like Goldman Sachs (GS), which could significantly validate the investment thesis behind the VCX Fund. However, the involvement of intermediaries in private SpaceX share ownership introduces complications and elevates fraud risks for indirect holders such as VCX investors.
While hype has driven VCX’s premium over NAV to as high as 2,300% at times, the expiration of share lockups poses a threat of dilution that could unwind these gains.
Is VCX a Buy?
VCX has delivered strong short-term returns from top private tech bets. It suits aggressive traders chasing momentum, not long-term holders overpaying amid lockups. Investors should closely monitor the fund’s NAV and key holdings’ IPO timelines. Upside exists if valuations rise, but current risks outweigh rewards in this hype-driven market.
We used TipRanks’ Technical Analysis Tool to assess the outlook for the Fundrise Innovation Fund. The tool indicates a “Buy” consensus, with nine indicators showing Bullish signals, against one Neutral and six Bearish indicators.
